Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

NYU Langone Health South Shore Neurologic Associates, Patchogue

Dysautonomia Clinic, Buffalo

Penn Presbyterian Medical Center, Philadelphia

Johns Hopkins Bayview Medical Center PMR, Baltimore

VCU Health, Richmond

Velocity Clinical Research - Hampton, Hampton

Duke University Medical Center, Durham

Velocity Clinical Research - Union, Union

Velocity Clinical Research, Savannah, Savannah

Hope Research Network, Miami

Well Pharma Medical Research, Corp, Miami

Vanderbilt University Medical Center, Nashville

University Hospital Cleveland Medical Center, Cleveland

Bernstein Clinical Research Center, Cincinnati

Profound Research LLC at Millennium Affiliated Physicians, Farmington Hills

Velocity Clinical Research - Lincoln, Lincoln

LSU Health Sciences Center, New Orleans

Velocity Clinical Research, Metairie, New Orleans

Arkansas Cardiology Clinic - Little Rock, Little Rock

Hightower Clinical, Oklahoma City

Sunbeam Clinical Research, McKinney

University of Texas Southwestern Medical Center, Dallas

Prolato Clinical Research Center, Houston

University of Texas Health Science Center, San Antonio

UT Austin Dell Medical School, Austin

National Jewish Health, Denver

Bateman Horne Center, Salt Lake City

Metrodora Institute, West Valley City

Center for Complex Neurology, EDS & POTS, Phoenix

Mayo Clinic Arizona, Scottsdale

UC San Diego Health, La Jolla

University of california Irvine, Orange

University of Alabama Hospital at Birmingham, Birmingham

Mass General Brigham (Massachusetts General Hospital), Belmont

Libin Cardiovascular Institute University of Calgary, Calgary

University of Alberta Hospital, Edmonton

McGill University Health Centre, Québec

Ciussse-Chus, Sherbrooke